Vav1 is a guanine nucleotide exchange factor that selectively activates the Rac1 GTPase and is expressed specifically in haematopoietic cells. Recent work has revealed how Vav1 integrates signals from lymphocyte antigen receptors and costimulatory receptors to control immune function. GTPases function as binary switches by cycling between an active, GTP-bound state and an inactive, GDP-bound state. In their GTP-bound state, these proteins interact with specific effectors to initiate downstream signal transduction pathways. Guanine nucleotide exchange factors (GEFs) promote the transition from the inactive GDPbound state to the active GTP-bound conformation. Vav proteins are GEFs which show selectivity for the Rho family GTPase Rac1. Two closely related Vav proteins have been identified, Vav1 and Vav2. These molecules have a Dbl homology region, which marks the catalytic domain of GEFs specific for Rho GTPases, and contain one Src homology 2 (SH2) domain and two SH3 domains; SH2 domains bind to tyrosine-phosphorylated proteins, and SH3 domains bind to proline-rich peptides. The GEF activity of Vav1 is upregulated by tyrosine phosphorylation mediated by coexpression of Src family kinases [1, 2] . Vav1 is expressed exclusively in haematopoietic cells and, in a physiological context, Vav1 is an immediate substrate for tyrosine kinases following activation of B cells, T cells and mast cells (for review, see [3] ). Significantly, engagement of CD28 -the costimulatory receptor for the T-cell receptor -with its physiological ligands, B7-1 and B7-2, can induce a rapid and sustained tyrosine phosphorylation of Vav1 in T cells in the absence of simultaneous engagement of the T-cell receptor [4] . Vav1 is thus activated by the initial contact between T cells and antigen-presenting cells mediated by CD28-B7 interactions [5] .
GTPases function as binary switches by cycling between an active, GTP-bound state and an inactive, GDP-bound state. In their GTP-bound state, these proteins interact with specific effectors to initiate downstream signal transduction pathways. Guanine nucleotide exchange factors (GEFs) promote the transition from the inactive GDPbound state to the active GTP-bound conformation. Vav proteins are GEFs which show selectivity for the Rho family GTPase Rac1. Two closely related Vav proteins have been identified, Vav1 and Vav2. These molecules have a Dbl homology region, which marks the catalytic domain of GEFs specific for Rho GTPases, and contain one Src homology 2 (SH2) domain and two SH3 domains; SH2 domains bind to tyrosine-phosphorylated proteins, and SH3 domains bind to proline-rich peptides. The GEF activity of Vav1 is upregulated by tyrosine phosphorylation mediated by coexpression of Src family kinases [1, 2] . Vav1 is expressed exclusively in haematopoietic cells and, in a physiological context, Vav1 is an immediate substrate for tyrosine kinases following activation of B cells, T cells and mast cells (for review, see [3] ). Significantly, engagement of CD28 -the costimulatory receptor for the T-cell receptor -with its physiological ligands, B7-1 and B7-2, can induce a rapid and sustained tyrosine phosphorylation of Vav1 in T cells in the absence of simultaneous engagement of the T-cell receptor [4] . Vav1 is thus activated by the initial contact between T cells and antigen-presenting cells mediated by CD28-B7 interactions [5] .
The catalytic Dbl domain in Vav1 is flanked carboxy-terminally by a pleckstrin homology (PH) domain that can bind polyphosphoinositides [6] . It is thought that binding of these lipids to PH domains of GEFs either allosterically modifies GEF activity, or facilitates activation of the GEF by inducing its relocalisation to specific subcellular locations or defined areas of the plasma membrane where activation can occur. Activation of the phospholipid kinase phosphatidylinositol (PI) 3-kinase and the consequent elevation of intracellular levels of D-3 phosphoinositides is a common response to triggering of antigen receptors, costimulatory receptors and cytokine receptors. The PH domain of Vav1 binds in vitro to PI 3,4,5-triphosphate, a product of the reaction catalysed by PI 3-kinase, and this promotes phosphorylation of Vav1 by tyrosine kinases thereby activating Vav1's catalytic function [6] . Binding of lipid products of the reaction catalysed by PI 3-kinase to the PH domains of Vav1 may also induce relocalisation of the protein to specific cellular locations where activation can occur.
Other mechanisms that regulate the localisation of Vav1 have also been described. A protein complex between Vav1 and the adaptor protein SLP-76 is formed in response to antigen receptor stimulation in T cells [5] . Vav1 also binds via its SH2 domain to the tyrosine kinase ZAP-70 [7] . These interactions target Vav1 into activated T-cell receptor complexes. In B cells, CD19 is the coreceptor that amplifies antigen receptor function. Coligation of CD19 with the B-cell receptor results in the tyrosine phosphorylation of CD19 on a high affinity docking site for the SH2 domain of Vav1 [8] , leading to the subsequent recruitment of Vav1 to CD19. In biochemical terms, Vav1 integrates signals from antigen receptors and costimulatory molecules and is colocalised with these receptor complexes during lymphocyte activation ( Figure 1 ).
The role of Vav1 in lymphocytes
The above biochemical studies of Vav1 predicted that this molecule has an important role in lymphocytes and this was confirmed by analyses of Vav1-deficient mice. These animals display various defects in T-cell and B-cell development. Processes that shape the T-cell repertoire are defective in Vav1-deficient mice, with T-cell selection events in the thymus being affected as well as the production of peripheral T cells [9] . Moreover, peripheral T lymphocytes in Vav1-deficient mice fail to proliferate in response to antigen-receptor engagement [10, 11] . The molecular basis for this proliferative defect is a failure of Vav1-deficient T cells to produce the T-cell growth factor interleukin-2 (IL-2). A role for Vav1 in the induction of cytokine genes is also revealed by experiments performed in cultured T-cell lines. Overexpression of Vav1 was found to dramatically potentiate antigen-mediated transcriptional activation of nuclear factor of activated T cells (NFAT) [12] , a family of molecules that control antigenreceptor-induced activation of genes for cytokines such as IL-2, IL-4, granulocyte macrophage colony-stimulating factor or tumour necrosis factor α. The key question has been, how does Vav1 impinge on the intracellular signalling networks that control lymphocyte function?
Vav1 regulates intracellular calcium levels in T cells and B cells
The immediate consequence of antigen receptor ligation is the activation of tyrosine kinases; Lck, Fyn and ZAP-70 in T cells, and Lyn and Syk in B cells and mast cells. One role for these tyrosine kinases is to couple antigen receptors to phospholipase Cγ1 or phospholipase Cγ2 which control the hydrolysis of the inositol lipid PI 4,5-bisphosphate (PIP 2 ) thereby generating inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerols, which regulate intracellular calcium and protein kinase C, respectively. In Vav1-deficient lymphocytes, there are apparently no problems with the activation of tyrosine kinases. However, Vav1-deficient T cells fail to sustain elevated levels of intracellular calcium in response to antigen receptor stimulation [9] [10] [11] . There are also significant problems with calcium homeostasis in Vav1-deficient B cells following engagement of antigen receptors and CD19 [8] .
The molecular basis for the defects in calcium signalling in Vav1-deficient B cells has been analysed in detail and has been shown to result from impaired inositol lipid biosynthesis [8] . Coligation of the B-cell coreceptor CD19 with antigen receptors normally results in activation of PI 4-phosphate (PIP) 5-kinase [8] , which phosphorylates PIP thus generating PIP 2 , the substrate for phospholipase C and the essential precursor for the production of IP 3 which regulates intracellular calcium. The activation of PIP 5-kinase is absolutely required for the continued biosynthesis of PIP 2 and the sustained production of IP 3 . O'Rourke et al. [8] found that Vav1 provides the link between CD19 and PIP 5-kinase. CD19 recruits Vav1 to the plasma membrane for activation and Rac1, the main target for Vav1 in lymphocytes, can bind to PIP 5-kinase and stimulate its activity. Hence, the failure of Vav1-deficient lymphocytes to maintain calcium signals in response to antigen receptor and CD19 coligation is attributable to the inability to regulate inositol lipid biosynthesis via Vav1 and Rac1. A similar analysis of inositol phospholipid metabolism in Vav1-deficient T cells has not yet been performed. Nevertheless, activation of PIP 5-kinases is certainly essential for the sustained hydrolysis of inositol phospholipids in T lymphocytes and it would seem likely that the model for Vav1 and Rac1 regulation of calcium that has been established in B cells is also applicable to T lymphocytes.
Vav1 regulates the actin cytoskeleton in lymphocytes
Overexpression of Vav1 in fibroblasts induces a dynamic reorganisation of the actin cytoskeleton and the assembly of integrin signalling complexes [13] . Vav1 has been shown to initiate Rac1-mediated formation of lamellipodia and focal complexes and the formation of actin stress fibres and focal adhesions mediated by the RhoA GTPase. Consistent with the regulatory effects of Vav1 on Rac1 and on RhoA, severe defects in the regulation of the actin cytoskeleton occur in Vav1-deficient lymphocytes [10, 11] . At present it is not clear how Vav1 and Rac1 regulate the actin cytoskeleton, but the role of these molecules in controlling cellular levels of PIP 2 and calcium could be relevant because of the established links between these processes and the assembly of actin structures. However, a variety of Rac1 effectors including the p21-activated kinase (Pak) family of serine/threonine kinases, mixed lineage kinase (MLK) 2,3, the tyrosine kinase p120 Ack , POR1 (partner of Rac1), and the mitogenactivated protein kinase kinase kinase Mekk1,4 have been identified. Vav1, and hence Rac1, therefore have the potential to regulate diverse cellular responses because they can couple to multiple effector pathways (Figure 2 ). 
An intact actin cytoskeleton is required for NFAT transcriptional activity
The importance of the actin cytoskeleton for lymphocyte responses is already clear. First, sustained triggering of antigen receptors is dependent on the maintenance of the actin cytoskeleton. Second, the actin cytoskeleton also controls the polarisation of T cells towards antigen-presenting cells, a process that is critical for efficient contact between antigen-presenting cells and T cells and for the directed release of cytokines and other effector molecules. Disruption of the contacts between antigen-presenting cells and T cells would thus indirectly block T-cell signal transduction. Nevertheless, a striking observation from recent studies of Vav1 function in lymphocytes is that there is a more direct role for actin-regulated events in the transmission of signals that regulate induction of cytokine genes [11] .
The transcription factor NFAT has an essential role in cytokine gene induction. Activation of NFAT requires the coordinated interaction of sustained calcium signals and signalling pathways initiated by Rac1 and another GTPase Ras. NFAT molecules are cytosolic in quiescent lymphocytes and translocate to the nucleus via a calcium-calcineurin-regulated mechanism. In the nucleus, NFAT molecules form transcriptionally active complexes with proteins of the activator protein 1 (AP-1) family. Rac1 can be positioned at two different points in the regulation of NFAT: first in the antigen-receptor-controlled pathway that regulates NFAT cellular localisation, and second in the antigen-receptor-controlled and Ras-mediated pathways that control AP-1 expression and function [14, 15] . Crabtree and colleagues [11] have now identified a Vav1-regulated actin-dependent pathway that is required for NFAT activation. They found that disruption of the actin cytoskeleton has no impact on the elevation of intracellular calcium mediated by the antigen receptor, therefore the requirement for an intact actin cytoskeleton for NFAT transcriptional activity must be independent of the calcium signal [11] . Furthermore, NFAT nuclear trans location apparently occurs normally without Vav1 function, a surprising finding given the calcium signalling defects in Vav1-deficient lymphocytes. The actin-regulated signalling pathway controlled by Vav1 thus regulates the transcriptional activity of NFAT complexes that are already localised in the nucleus.
Do Vav1-deficient lymphocytes lose all Rac1 function?
Biochemical quantitation of active Rac1 complexes has not been carried out in Vav1-deficient lymphocytes, so it is not known whether these cells have lost all Rac1 function. The activation of one of the Rac1 effectors, Pak1, is normal in Vav1-deficient lymphocytes, however, which raises the possibility that there is residual Rac1 signalling in Vav1-deficient cells [10] . Moreover, Rac1 function is required for NFAT nuclear import whereas NFAT translocation occurs normally in Vav1-deficient lymphocytes [11, 15] In summary, two critical functions for Vav1 in lymphocytes have now been identified. The activation of Vav1 by the coreceptors for the antigen receptors controls inositol lipid metabolism and sets a threshold that regulates the calcium responses induced by antigen-receptor signalling [7] . Vav1 also controls the actin cytoskeleton and allows antigen receptors to regulate the transcriptional activity of nuclear localised NFAT [10, 11] . These different functions for Vav1 in lymphocytes demonstrate that Rac1 can regulate disparate effector targets. Ultimately, the details of Vav1 function will be determined by the unique expression patterns of different Rac1 effector molecules in distinct cell types. 
